|

Larotrectinib Clinical Trials

4 actively recruiting trials across 1 location

Also known as: VITRAKVI

Pipeline

Early 1: 1Phase 2: 3

Top Sponsors

  • West China Hospital1
  • Sun Yat-sen University1
  • Oslo University Hospital1
  • Nationwide Children's Hospital1

Indications

  • Cancer4
  • Locally Advanced Thyroid Gland Carcinoma1
  • Mutation1
  • Lung Cancer Stage III1
  • Diffuse Intrinsic Pontine Glioma1

Other3 trials

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
Phase 2
Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.
Phase 2
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
Phase 2

Aurora, Colorado1 trial

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Children's Hospital Colorado

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.